Antifungal drug resistance of pathogenic fungi

被引：357
作者：
Kontoyiannis, DP
Lewis, RE
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Houston, Coll Pharm, Houston, TX 77030 USA
来源：
LANCET | 2002年 / 359卷 / 9312期
关键词：
D O I：
10.1016/S0140-6736(02)08162-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pathogenic fungi have many complex mechanisms of resistance to antifungal drugs. Information about the clinical, cellular, and molecular factors contributing to antifungal-drug resistance continues to accumulate. We critically review the diagnosis, epidemiology, and mechanisms of antifungal drug resistance of pathogenic fungi. Better understanding of this resistance should assist in developing better detection strategies for preventing and treating refractory mycoses In the future.
引用
收藏
页码：1135 / 1144
页数：10
相关论文
共 119 条
[91]   The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals [J].
Schorling, SR ;
Kortinga, HC ;
Froschb, M ;
Mühlschlegel, FA .
CRITICAL REVIEWS IN MICROBIOLOGY, 2000, 26 (01) :59-68
[92]   Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus [J].
Seo, K ;
Akiyoshi, H ;
Ohnishi, Y .
MICROBIOLOGY AND IMMUNOLOGY, 1999, 43 (11) :1017-1025
[93]   Current and emerging azole antifungal agents [J].
Sheehan, DJ ;
Hitchcock, CA ;
Sibley, CM .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) :40-+
[94]   Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals (Reprinted from Infection Control and Hospital Epidemiology, vol 18, pg 275-91, 1997) [J].
Shlaes, DM ;
Gerding, DN ;
John, JF ;
Craig, WA ;
Bornstein, DL ;
Duncan, RA ;
Eckman, MR ;
Farrer, WE ;
Greene, WH ;
Lorian, V ;
Levy, S ;
McGowan, JE ;
Paul, SM ;
Ruskin, J ;
Tenover, FC ;
Watanakunakorn, C .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :584-599
[95]   The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women [J].
Sobel, JD ;
Ohmit, SE ;
Schuman, P ;
Klein, RS ;
Mayer, K ;
Duerr, A ;
Vazquez, JA ;
Rompalo, A .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (02) :286-293
[96]   ROLE OF CELL DEFENSE AGAINST OXIDATIVE DAMAGE IN THE RESISTANCE OF CANDIDA-ALBICANS TO THE KILLING EFFECT OF AMPHOTERICIN-B [J].
SOKOLANDERSON, M ;
SLIGH, JE ;
ELBERG, S ;
BRAJTBURG, J ;
KOBAYASHI, GS ;
MEDOFF, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :702-705
[97]   The ins and outs of DNA fingerprinting the infectious fungi [J].
Soll, DR .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (02) :332-+
[98]   Combination immunotherapy and antifungal chemotherapy [J].
Stevens, DA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) :1266-1269
[99]   In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus [J].
Taylor, BN ;
Fichtenbaum, C ;
Saavedra, M ;
Slavinsky, J ;
Swoboda, R ;
Wozniak, K ;
Arribas, A ;
Powderly, W ;
Fidel, PL .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :955-959
[100]   Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus [J].
Tobin, MB ;
Peery, RB ;
Skatrud, PL .
GENE, 1997, 200 (1-2) :11-23
3456789101112